Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Acute myeloid leukemia
| Copanlisib | 121 1件: 121 💬1. Acute myeloid leukemia
|
|||||||||||||||||
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬AGE-RAGE signaling pathway in diabetic complications
| Copanlisib | 121 1件: 121 💬2. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||
| 3 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Aldosterone-regulated sodium reabsorption
| Copanlisib | 121 1件: 121 💬3. Aldosterone-regulated sodium reabsorption
|
|||||||||||||||||
| 4 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Alzheimer disease
| Copanlisib | 121 1件: 121 💬4. Alzheimer disease
|
|||||||||||||||||
| 5 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Amoebiasis
| Copanlisib | 121 1件: 121 💬5. Amoebiasis
|
|||||||||||||||||
| 6 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬AMPK signaling pathway
| Copanlisib | 121 1件: 121 💬6. AMPK signaling pathway
|
|||||||||||||||||
| 7 | Apoptosis 💬 18 genes, 32 drugs (DrugBank) and 68 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Apoptosis
| Copanlisib | 121 1件: 121 💬7. Apoptosis
|
|||||||||||||||||
| 8 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Autophagy - animal
| Copanlisib | 121 1件: 121 💬8. Autophagy - animal
|
|||||||||||||||||
| 9 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 73 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Axon guidance
| Copanlisib | 121 1件: 121 💬9. Axon guidance
|
|||||||||||||||||
| 10 | B cell receptor signaling pathway 💬 19 genes, 38 drugs (DrugBank) and 68 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬B cell receptor signaling pathway
| Copanlisib | 121 1件: 121 💬10. B cell receptor signaling pathway
|
|||||||||||||||||
| 11 | Bacterial invasion of epithelial cells 💬 7 genes, 10 drugs (DrugBank) and 24 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Bacterial invasion of epithelial cells
| Copanlisib | 121 1件: 121 💬11. Bacterial invasion of epithelial cells
|
|||||||||||||||||
| 12 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Breast cancer
| Copanlisib | 121 1件: 121 💬12. Breast cancer
|
|||||||||||||||||
| 13 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬C-type lectin receptor signaling pathway
| Copanlisib | 121 1件: 121 💬13. C-type lectin receptor signaling pathway
|
|||||||||||||||||
| 14 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬cAMP signaling pathway
| Copanlisib | 121 1件: 121 💬14. cAMP signaling pathway
|
|||||||||||||||||
| 15 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Carbohydrate digestion and absorption
| Copanlisib | 121 1件: 121 💬15. Carbohydrate digestion and absorption
|
|||||||||||||||||
| 16 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Cellular senescence
| Copanlisib | 121 1件: 121 💬16. Cellular senescence
|
|||||||||||||||||
| 17 | Central carbon metabolism in cancer 💬 20 genes, 37 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Central carbon metabolism in cancer
| Copanlisib | 121 1件: 121 💬17. Central carbon metabolism in cancer
|
|||||||||||||||||
| 18 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chagas disease
| Copanlisib | 121 1件: 121 💬18. Chagas disease
|
|||||||||||||||||
| 19 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - reactive oxygen species
| Copanlisib | 121 1件: 121 💬19. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||
| 20 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - receptor activation
| Copanlisib | 121 1件: 121 💬20. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||
| 21 | Chemokine signaling pathway 💬 25 genes, 38 drugs (DrugBank) and 66 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemokine signaling pathway
| Copanlisib | 121 1件: 121 💬21. Chemokine signaling pathway
|
|||||||||||||||||
| 22 | Choline metabolism in cancer 💬 11 genes, 29 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Choline metabolism in cancer
| Copanlisib | 121 1件: 121 💬22. Choline metabolism in cancer
|
|||||||||||||||||
| 23 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Cholinergic synapse
| Copanlisib | 121 1件: 121 💬23. Cholinergic synapse
|
|||||||||||||||||
| 24 | Chronic myeloid leukemia 💬 18 genes, 23 drugs (DrugBank) and 39 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chronic myeloid leukemia
| Copanlisib | 121 1件: 121 💬24. Chronic myeloid leukemia
|
|||||||||||||||||
| 25 | Colorectal cancer 💬 15 genes, 27 drugs (DrugBank) and 62 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Colorectal cancer
| Copanlisib | 121 1件: 121 💬25. Colorectal cancer
|
|||||||||||||||||
| 26 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Coronavirus disease
| Copanlisib | 121 1件: 121 💬26. Coronavirus disease
|
|||||||||||||||||
| 27 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Diabetic cardiomyopathy
| Copanlisib | 121 1件: 121 💬27. Diabetic cardiomyopathy
|
|||||||||||||||||
| 28 | Endometrial cancer 💬 10 genes, 19 drugs (DrugBank) and 28 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Endometrial cancer
| Copanlisib | 121 1件: 121 💬28. Endometrial cancer
|
|||||||||||||||||
| 29 | Epstein-Barr virus infection 💬 67 genes, 97 drugs (DrugBank) and 83 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Epstein-Barr virus infection
| Copanlisib | 121 1件: 121 💬29. Epstein-Barr virus infection
|
|||||||||||||||||
| 30 | ErbB signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬ErbB signaling pathway
| Copanlisib | 121 1件: 121 💬30. ErbB signaling pathway
|
|||||||||||||||||
| 31 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Estrogen signaling pathway
| Copanlisib | 121 1件: 121 💬31. Estrogen signaling pathway
|
|||||||||||||||||
| 32 | Fc epsilon RI signaling pathway 💬 19 genes, 49 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fc epsilon RI signaling pathway
| Copanlisib | 121 1件: 121 💬32. Fc epsilon RI signaling pathway
|
|||||||||||||||||
| 33 | Fc gamma R-mediated phagosome formation 💬 9 genes, 13 drugs (DrugBank) and 20 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fc gamma R-mediated phagosome formation
| Copanlisib | 121 1件: 121 💬33. Fc gamma R-mediated phagosome formation
|
|||||||||||||||||
| 34 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fluid shear stress and atherosclerosis
| Copanlisib | 121 1件: 121 💬34. Fluid shear stress and atherosclerosis
|
|||||||||||||||||
| 35 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Focal adhesion
| Copanlisib | 121 1件: 121 💬35. Focal adhesion
|
|||||||||||||||||
| 36 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬FoxO signaling pathway
| Copanlisib | 121 1件: 121 💬36. FoxO signaling pathway
|
|||||||||||||||||
| 37 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Gastric cancer
| Copanlisib | 121 1件: 121 💬37. Gastric cancer
|
|||||||||||||||||
| 38 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Glioma
| Copanlisib | 121 1件: 121 💬38. Glioma
|
|||||||||||||||||
| 39 | GnRH secretion 💬 27 genes, 49 drugs (DrugBank) and 62 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬GnRH secretion
| Copanlisib | 121 1件: 121 💬39. GnRH secretion
|
|||||||||||||||||
| 40 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Growth hormone synthesis, secretion and action
| Copanlisib | 121 1件: 121 💬40. Growth hormone synthesis, secretion and action
|
|||||||||||||||||
| 41 | Hepatitis B 💬 44 genes, 70 drugs (DrugBank) and 92 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatitis B
| Copanlisib | 121 1件: 121 💬41. Hepatitis B
|
|||||||||||||||||
| 42 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatitis C
| Copanlisib | 121 1件: 121 💬42. Hepatitis C
|
|||||||||||||||||
| 43 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatocellular carcinoma
| Copanlisib | 121 1件: 121 💬43. Hepatocellular carcinoma
|
|||||||||||||||||
| 44 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Herpes simplex virus 1 infection
| Copanlisib | 121 1件: 121 💬44. Herpes simplex virus 1 infection
|
|||||||||||||||||
| 45 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬HIF-1 signaling pathway
| Copanlisib | 121 1件: 121 💬45. HIF-1 signaling pathway
|
|||||||||||||||||
| 46 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hormone signaling
| Copanlisib | 121 1件: 121 💬46. Hormone signaling
|
|||||||||||||||||
| 47 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human cytomegalovirus infection
| Copanlisib | 121 1件: 121 💬47. Human cytomegalovirus infection
|
|||||||||||||||||
| 48 | Human immunodeficiency virus 1 infection 💬 51 genes, 59 drugs (DrugBank) and 98 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human immunodeficiency virus 1 infection
| Copanlisib | 121 1件: 121 💬48. Human immunodeficiency virus 1 infection
|
|||||||||||||||||
| 49 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human papillomavirus infection
| Copanlisib | 121 1件: 121 💬49. Human papillomavirus infection
|
|||||||||||||||||
| 50 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human T-cell leukemia virus 1 infection
| Copanlisib | 121 1件: 121 💬50. Human T-cell leukemia virus 1 infection
|
|||||||||||||||||
| 51 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬IgSF CAM signaling
| Copanlisib | 121 1件: 121 💬51. IgSF CAM signaling
|
|||||||||||||||||
| 52 | Inflammatory mediator regulation of TRP channels 💬 26 genes, 55 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Inflammatory mediator regulation of TRP channels
| Copanlisib | 121 1件: 121 💬52. Inflammatory mediator regulation of TRP channels
|
|||||||||||||||||
| 53 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Influenza A
| Copanlisib | 121 1件: 121 💬53. Influenza A
|
|||||||||||||||||
| 54 | Inositol phosphate metabolism 💬 4 genes, 5 drugs (DrugBank) and 10 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Inositol phosphate metabolism
| Copanlisib | 121 1件: 121 💬54. Inositol phosphate metabolism
|
|||||||||||||||||
| 55 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Insulin resistance
| Copanlisib | 121 1件: 121 💬55. Insulin resistance
|
|||||||||||||||||
| 56 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Insulin signaling pathway
| Copanlisib | 121 1件: 121 💬56. Insulin signaling pathway
|
|||||||||||||||||
| 57 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Integrin signaling
| Copanlisib | 121 1件: 121 💬57. Integrin signaling
|
|||||||||||||||||
| 58 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬JAK-STAT signaling pathway
| Copanlisib | 121 1件: 121 💬58. JAK-STAT signaling pathway
|
|||||||||||||||||
| 59 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Kaposi sarcoma-associated herpesvirus infection
| Copanlisib | 121 1件: 121 💬59. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||
| 60 | Leukocyte transendothelial migration 💬 19 genes, 23 drugs (DrugBank) and 37 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Leukocyte transendothelial migration
| Copanlisib | 121 1件: 121 💬60. Leukocyte transendothelial migration
|
|||||||||||||||||
| 61 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Lipid and atherosclerosis
| Copanlisib | 121 1件: 121 💬61. Lipid and atherosclerosis
|
|||||||||||||||||
| 62 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Longevity regulating pathway
| Copanlisib | 121 1件: 121 💬62. Longevity regulating pathway
|
|||||||||||||||||
| 63 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Longevity regulating pathway - multiple species
| Copanlisib | 121 1件: 121 💬63. Longevity regulating pathway - multiple species
|
|||||||||||||||||
| 64 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Measles
| Copanlisib | 121 1件: 121 💬64. Measles
|
|||||||||||||||||
| 65 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Melanoma
| Copanlisib | 121 1件: 121 💬65. Melanoma
|
|||||||||||||||||
| 66 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬MicroRNAs in cancer
| Copanlisib | 121 1件: 121 💬66. MicroRNAs in cancer
|
|||||||||||||||||
| 67 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬mTOR signaling pathway
| Copanlisib | 121 1件: 121 💬67. mTOR signaling pathway
|
|||||||||||||||||
| 68 | Natural killer cell mediated cytotoxicity 💬 45 genes, 49 drugs (DrugBank) and 91 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Natural killer cell mediated cytotoxicity
| Copanlisib | 121 1件: 121 💬68. Natural killer cell mediated cytotoxicity
|
|||||||||||||||||
| 69 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Neuroactive ligand signaling
| Desipramine | 121 2件: 121, 156 💬69. Neuroactive ligand signaling
|
|||||||||||||||||
| 70 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Neuroactive ligand signaling
| Desipramine | 121 2件: 121, 156 💬69. Neuroactive ligand signaling
|
|||||||||||||||||
| 71 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 38 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Neurotrophin signaling pathway
| Copanlisib | 121 1件: 121 💬71. Neurotrophin signaling pathway
|
|||||||||||||||||
| 72 | Neutrophil extracellular trap formation 💬 37 genes, 45 drugs (DrugBank) and 78 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Neutrophil extracellular trap formation
| Copanlisib | 121 1件: 121 💬72. Neutrophil extracellular trap formation
|
|||||||||||||||||
| 73 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Non-alcoholic fatty liver disease
| Copanlisib | 121 1件: 121 💬73. Non-alcoholic fatty liver disease
|
|||||||||||||||||
| 74 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Non-small cell lung cancer
| Copanlisib | 121 1件: 121 💬74. Non-small cell lung cancer
|
|||||||||||||||||
| 75 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Osteoclast differentiation
| Copanlisib | 121 1件: 121 💬75. Osteoclast differentiation
|
|||||||||||||||||
| 76 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Pancreatic cancer
| Copanlisib | 121 1件: 121 💬76. Pancreatic cancer
|
|||||||||||||||||
| 77 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Pathways in cancer
| Copanlisib | 121 1件: 121 💬77. Pathways in cancer
|
|||||||||||||||||
| 78 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Copanlisib | 121 1件: 121 💬78. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
|||||||||||||||||
| 79 | Phagocytosis 💬 44 genes, 34 drugs (DrugBank) and 43 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phagocytosis
| Copanlisib | 121 1件: 121 💬79. Phagocytosis
|
|||||||||||||||||
| 80 | Phosphatidylinositol signaling system 💬 5 genes, 6 drugs (DrugBank) and 11 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phosphatidylinositol signaling system
| Copanlisib | 121 1件: 121 💬80. Phosphatidylinositol signaling system
|
|||||||||||||||||
| 81 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phospholipase D signaling pathway
| Copanlisib | 121 1件: 121 💬81. Phospholipase D signaling pathway
|
|||||||||||||||||
| 82 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬PI3K-Akt signaling pathway
| Copanlisib | 121 1件: 121 💬82. PI3K-Akt signaling pathway
|
|||||||||||||||||
| 83 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Platelet activation
| Copanlisib | 121 1件: 121 💬83. Platelet activation
|
|||||||||||||||||
| 84 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prion disease
| Copanlisib | 121 1件: 121 💬84. Prion disease
|
|||||||||||||||||
| 85 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Progesterone-mediated oocyte maturation
| Copanlisib | 121 1件: 121 💬85. Progesterone-mediated oocyte maturation
|
|||||||||||||||||
| 86 | Prolactin signaling pathway 💬 20 genes, 44 drugs (DrugBank) and 74 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prolactin signaling pathway
| Copanlisib | 121 1件: 121 💬86. Prolactin signaling pathway
|
|||||||||||||||||
| 87 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prostate cancer
| Copanlisib | 121 1件: 121 💬87. Prostate cancer
|
|||||||||||||||||
| 88 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Proteoglycans in cancer
| Copanlisib | 121 1件: 121 💬88. Proteoglycans in cancer
|
|||||||||||||||||
| 89 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Rap1 signaling pathway
| Copanlisib | 121 1件: 121 💬89. Rap1 signaling pathway
|
|||||||||||||||||
| 90 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Ras signaling pathway
| Copanlisib | 121 1件: 121 💬90. Ras signaling pathway
|
|||||||||||||||||
| 91 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Regulation of actin cytoskeleton
| Copanlisib | 121 1件: 121 💬91. Regulation of actin cytoskeleton
|
|||||||||||||||||
| 92 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Regulation of lipolysis in adipocytes
| Copanlisib | 121 1件: 121 💬92. Regulation of lipolysis in adipocytes
|
|||||||||||||||||
| 93 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Relaxin signaling pathway
| Copanlisib | 121 1件: 121 💬93. Relaxin signaling pathway
|
|||||||||||||||||
| 94 | Renal cell carcinoma 💬 15 genes, 16 drugs (DrugBank) and 32 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Renal cell carcinoma
| Copanlisib | 121 1件: 121 💬94. Renal cell carcinoma
|
|||||||||||||||||
| 95 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Salmonella infection
| Copanlisib | 121 1件: 121 💬95. Salmonella infection
|
|||||||||||||||||
| 96 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
SLC6A4 1件: SLC6A4 💬Serotonergic synapse
|
Desipramine hydrochloride Desipramine hydrochloride 💬Serotonergic synapse
| Desipramine | 121 2件: 121, 156 💬96. Serotonergic synapse
|
|||||||||||||||||
| 97 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
SLC6A4 1件: SLC6A4 💬Serotonergic synapse
|
Desipramine Desipramine 💬Serotonergic synapse
| Desipramine | 121 2件: 121, 156 💬96. Serotonergic synapse
|
|||||||||||||||||
| 98 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Shigellosis
| Copanlisib | 121 1件: 121 💬98. Shigellosis
|
|||||||||||||||||
| 99 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 39 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Signaling pathways regulating pluripotency of stem cells
| Copanlisib | 121 1件: 121 💬99. Signaling pathways regulating pluripotency of stem cells
|
|||||||||||||||||
| 100 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Small cell lung cancer
| Copanlisib | 121 1件: 121 💬100. Small cell lung cancer
|
|||||||||||||||||
| 101 | Sphingolipid signaling pathway 💬 32 genes, 56 drugs (DrugBank) and 84 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Sphingolipid signaling pathway
| Copanlisib | 121 1件: 121 💬101. Sphingolipid signaling pathway
|
|||||||||||||||||
| 102 | Spinocerebellar ataxia 💬 18 genes, 30 drugs (DrugBank) and 79 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Spinocerebellar ataxia
| Copanlisib | 121 1件: 121 💬102. Spinocerebellar ataxia
|
|||||||||||||||||
| 103 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Synaptic vesicle cycle
| Desipramine | 121 2件: 121, 156 💬103. Synaptic vesicle cycle
|
|||||||||||||||||
| 104 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Synaptic vesicle cycle
| Desipramine | 121 2件: 121, 156 💬103. Synaptic vesicle cycle
|
|||||||||||||||||
| 105 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬T cell receptor signaling pathway
| Copanlisib | 121 1件: 121 💬105. T cell receptor signaling pathway
|
|||||||||||||||||
| 106 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Thyroid hormone signaling pathway
| Copanlisib | 121 1件: 121 💬106. Thyroid hormone signaling pathway
|
|||||||||||||||||
| 107 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬TNF signaling pathway
| Copanlisib | 121 1件: 121 💬107. TNF signaling pathway
|
|||||||||||||||||
| 108 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Toll-like receptor signaling pathway
| Copanlisib | 121 1件: 121 💬108. Toll-like receptor signaling pathway
|
|||||||||||||||||
| 109 | Type II diabetes mellitus 💬 15 genes, 44 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Type II diabetes mellitus
| Copanlisib | 121 1件: 121 💬109. Type II diabetes mellitus
|
|||||||||||||||||
| 110 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬VEGF signaling pathway
| Copanlisib | 121 1件: 121 💬110. VEGF signaling pathway
|
|||||||||||||||||
| 111 | Viral carcinogenesis 💬 32 genes, 34 drugs (DrugBank) and 60 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Viral carcinogenesis
| Copanlisib | 121 1件: 121 💬111. Viral carcinogenesis
|
|||||||||||||||||
| 112 | Yersinia infection 💬 25 genes, 43 drugs (DrugBank) and 78 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Yersinia infection
| Copanlisib | 121 1件: 121 💬112. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 34 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 77 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Apoptosis
18 genes, 32 drugs (DrugBank) and 68 diseases
Autophagy - animal
14 genes, 21 drugs (DrugBank) and 71 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 73 diseases
B cell receptor signaling pathway
19 genes, 38 drugs (DrugBank) and 68 diseases
Bacterial invasion of epithelial cells
7 genes, 10 drugs (DrugBank) and 24 diseases
Breast cancer
22 genes, 64 drugs (DrugBank) and 84 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Carbohydrate digestion and absorption
13 genes, 22 drugs (DrugBank) and 40 diseases
Cellular senescence
35 genes, 48 drugs (DrugBank) and 97 diseases
Central carbon metabolism in cancer
20 genes, 37 drugs (DrugBank) and 70 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - reactive oxygen species
24 genes, 37 drugs (DrugBank) and 53 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Chemokine signaling pathway
25 genes, 38 drugs (DrugBank) and 66 diseases
Choline metabolism in cancer
11 genes, 29 drugs (DrugBank) and 64 diseases
Cholinergic synapse
32 genes, 65 drugs (DrugBank) and 87 diseases
Chronic myeloid leukemia
18 genes, 23 drugs (DrugBank) and 39 diseases
Colorectal cancer
15 genes, 27 drugs (DrugBank) and 62 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Endometrial cancer
10 genes, 19 drugs (DrugBank) and 28 diseases
Epstein-Barr virus infection
67 genes, 97 drugs (DrugBank) and 83 diseases
ErbB signaling pathway
14 genes, 27 drugs (DrugBank) and 65 diseases
Estrogen signaling pathway
20 genes, 80 drugs (DrugBank) and 70 diseases
Fc epsilon RI signaling pathway
19 genes, 49 drugs (DrugBank) and 71 diseases
Fc gamma R-mediated phagosome formation
9 genes, 13 drugs (DrugBank) and 20 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Focal adhesion
31 genes, 52 drugs (DrugBank) and 54 diseases
FoxO signaling pathway
26 genes, 43 drugs (DrugBank) and 62 diseases
Gastric cancer
23 genes, 41 drugs (DrugBank) and 69 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 67 diseases
GnRH secretion
27 genes, 49 drugs (DrugBank) and 62 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 97 diseases
Hepatitis B
44 genes, 70 drugs (DrugBank) and 92 diseases
Hepatitis C
37 genes, 75 drugs (DrugBank) and 92 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Herpes simplex virus 1 infection
71 genes, 85 drugs (DrugBank) and 110 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human immunodeficiency virus 1 infection
51 genes, 59 drugs (DrugBank) and 98 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Human T-cell leukemia virus 1 infection
61 genes, 80 drugs (DrugBank) and 105 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
Inflammatory mediator regulation of TRP channels
26 genes, 55 drugs (DrugBank) and 70 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
Inositol phosphate metabolism
4 genes, 5 drugs (DrugBank) and 10 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 104 diseases
Insulin signaling pathway
13 genes, 28 drugs (DrugBank) and 74 diseases
Integrin signaling
28 genes, 48 drugs (DrugBank) and 77 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leukocyte transendothelial migration
19 genes, 23 drugs (DrugBank) and 37 diseases
Lipid and atherosclerosis
52 genes, 73 drugs (DrugBank) and 107 diseases
Longevity regulating pathway
11 genes, 23 drugs (DrugBank) and 73 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 70 diseases
Measles
42 genes, 72 drugs (DrugBank) and 70 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 45 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
mTOR signaling pathway
15 genes, 33 drugs (DrugBank) and 99 diseases
Natural killer cell mediated cytotoxicity
45 genes, 49 drugs (DrugBank) and 91 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 38 diseases
Neutrophil extracellular trap formation
37 genes, 45 drugs (DrugBank) and 78 diseases
Non-alcoholic fatty liver disease
24 genes, 54 drugs (DrugBank) and 100 diseases
Non-small cell lung cancer
21 genes, 39 drugs (DrugBank) and 57 diseases
Osteoclast differentiation
40 genes, 93 drugs (DrugBank) and 109 diseases
Pancreatic cancer
20 genes, 43 drugs (DrugBank) and 86 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 70 drugs (DrugBank) and 104 diseases
Phagocytosis
44 genes, 34 drugs (DrugBank) and 43 diseases
Phosphatidylinositol signaling system
5 genes, 6 drugs (DrugBank) and 11 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Progesterone-mediated oocyte maturation
14 genes, 39 drugs (DrugBank) and 47 diseases
Prolactin signaling pathway
20 genes, 44 drugs (DrugBank) and 74 diseases
Prostate cancer
24 genes, 58 drugs (DrugBank) and 92 diseases
Proteoglycans in cancer
34 genes, 75 drugs (DrugBank) and 107 diseases
Rap1 signaling pathway
47 genes, 115 drugs (DrugBank) and 101 diseases
Ras signaling pathway
38 genes, 65 drugs (DrugBank) and 77 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renal cell carcinoma
15 genes, 16 drugs (DrugBank) and 32 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Shigellosis
31 genes, 54 drugs (DrugBank) and 97 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 39 drugs (DrugBank) and 64 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Sphingolipid signaling pathway
32 genes, 56 drugs (DrugBank) and 84 diseases
Spinocerebellar ataxia
18 genes, 30 drugs (DrugBank) and 79 diseases
Synaptic vesicle cycle
8 genes, 32 drugs (DrugBank) and 43 diseases
T cell receptor signaling pathway
35 genes, 58 drugs (DrugBank) and 88 diseases
Thyroid hormone signaling pathway
25 genes, 46 drugs (DrugBank) and 78 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Toll-like receptor signaling pathway
41 genes, 68 drugs (DrugBank) and 84 diseases
Type II diabetes mellitus
15 genes, 44 drugs (DrugBank) and 100 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
Viral carcinogenesis
32 genes, 34 drugs (DrugBank) and 60 diseases
Yersinia infection
25 genes, 43 drugs (DrugBank) and 78 diseases
